Spx, a global transcription regulator in Bacillus subtilis, interacts with the C-terminal domain of the ␣ subunit (␣CTD) of RNA polymerase to control gene expression under conditions of disulfide stress, which is sensed by disulfide bond formation between Spx residues C10 and C13. Here, we describe the crystal structure of the B. subtilis ␣CTD bound to oxidized Spx. Analysis of the complex reveals interactions between three regions of ''antialpha'' Spx and helix ␣1 and the ''261'' determinant of ␣CTD. The former contact could disrupt the interaction between ␣CTD and activator proteins or alter the DNA-bound conformation of ␣CTD, thereby repressing activator-stimulated transcription. Binding to the 261 determinant would prevent interaction between ␣CTD and region 4 of A . Intriguingly, the Spx disulfide bond is far from the ␣CTD-Spx interface, suggesting that Spx regulates transcription allosterically or through the redox-dependent creation or destruction of binding sites for additional components of the transcription machinery.
B
acillus subtilis Spx is a global transcription factor that regulates the transcription of multiple genes in response to disulfide stress. The spx gene was first identified as a second site suppressor locus of clpP and clpX mutations (1) . ClpX is an ATPase that acts in concert with the ClpP protease to unfold and degrade targeted proteins. Spx has been shown to be a substrate for this protease, and in wild-type cells under normal growth conditions Spx is nearly undetectable because of its degradation (2) . The importance of the removal of Spx by ClpXP from cells during normal growth conditions was suggested by the findings that mutations in the clpP and clpX genes caused growth defects and blocked genetic competence and sporulation. Spx also blocks transcription of the srf operon, which encodes an essential competence regulatory gene (3, 4) and is positively regulated by the ComP-ComA two-component regulatory system (1, 5) .
Additional suppressor mutations of the clpX phenotype were mapped to codon substitutions in the rpoA gene, which encodes the ␣ subunit of RNA polymerase (6) . These point mutants, termed cxs for ClpX suppressor, corresponded to residues V260 and Y263, which are located in helix ␣1 of the C-terminal domain of the ␣ subunit of RNA polymerase (␣CTD). Helix ␣1 has been shown to be involved in activator stimulated transcription and RNA polymerase binding to UP elements as well as sequencenonspecific DNA interactions (7) (8) (9) (10) . Furthermore, in vitro transcription assays with native and cxs mutant containing RNA polymerase revealed that a direct interaction between Spx and ␣CTD is required for the repression of the srf operon, and hence, Spx has been termed an ''anti-alpha'' factor (2) .
Microarray analysis revealed that, along with repression of transcription of the srf operon and multiple other genes, transcription of the thioredoxin (trxA) and thioredoxin reductase (trxB) genes is induced when Spx is expressed in wild-type cells but not in cells containing the rpoA cxs-1 mutation, suggesting that Spx acts as a global regulator under conditions of disulfide stress (11) . More recently, Zuber and coworkers (12) demonstrated that both trxA and trxB are induced in wild-type cells but not in spx null or rpoA cxs-1 cells upon treatment with diamide, a reagent that induces oxidation of intracellular cysteines. In vitro transcription experiments revealed that Spx-stimulated transcription of trxA or trxB is abolished in the presence of reducing agent, which is consistent with the hypothesis that Spx acts to regulate genes involved in thiol homeostasis in response to disulfide stress conditions.
Spx is a monomeric, 15-kDa protein and belongs to the arsenate reductase (ArsC) family of proteins (13, 14) . The crystal structure of Escherichia coli ArsC bound to arsenate has been determined and revealed that the protein contains a fourstranded mixed ␤-sheet that is surrounded by ␣-helices (15) . Members of the ArsC family contain a conserved cysteine residue that is located in a loop between the first ␤-strand and the first ␣-helix and forms a covalent adduct with arsenate. In Gram-positive bacteria, Spx and its homologues contain a conserved CXXC motif, the first cysteine of which aligns with the conserved arsenate-ligating cysteine of ArsC (16) . Under normal reducing conditions, these cysteine residues in Spx are in their sulfhydryl form because electrospray-MS experiments with iodoacetamide-treated Spx under reducing and oxidizing conditions confirmed the alkylation of Spx under reducing but not oxidizing conditions (12) . Thus, the oxidation state of the Spx cysteines acts as a sensor of disulfide stress.
On the basis of accumulated genetic and biochemical evidence, a major role of Spx is to function as a global transcription regulator to restore the thiol balance of the cell under conditions of disulfide stress. Spx is unusual among bacterial transcriptional regulators in that it does not bind DNA as a part of its transcription regulatory role (12) . Rather, at the least, a direct interaction between Spx and ␣CTD is required for Spx to exert its regulatory effects at certain promoters. To understand the structural mechanism of transcription regulation by Spx via its interaction with the ␣ subunit of RNA polymerase, we determined the x-ray crystal structure of oxidized Spx in complex with ␣CTD to 1.5 Å resolution. The structure reveals direct interaction between Spx and ␣CTD residues, which are involved in the DNA, transcription activator, and subunit binding functions of this RNA polymerase subunit.
Materials and Methods
Protein Purification and Crystallization. Spx was overexpressed in E. coli as described in ref. 2 and purified by Ni 2ϩ -NTA affinity column chromatography (Qiagen). After elution from the Ni 2ϩ -NTA resin, Spx was incubated with tobacco-etch virus protease (TEV) to cleave the N-terminal His 6 -tag. Uncleaved Spx, along with the TEV protease, was removed by repassing the sample over a Ni 2ϩ -NTA column. Purified, cleaved Spx was dialyzed into 25 mM Pipes, pH 6.5͞100 mM KCl for use in subsequent crystallization trials.
␣CTD containing residues 245-314 from RpoA was cloned into the IMPACT self-cleavable intein vector (New England Biolabs) as described in ref. 2. The protein was purified by using the IMPACT self-cleavable affinity purification system (New England Biolabs). Purified ␣CTD was dialyzed into 25 mM Pipes, pH 6.5͞100 mM KCl. The Spx-␣CTD complex was formed by mixing equimolar amounts of purified Spx protein and ␣CTD. The complex was concentrated to 12 mg͞ml.
Selenomethionine-substituted Spx and ␣CTD were expressed by inhibiting the methionine biosynthetic pathway and supplementing with selenomethionine (17) . Both proteins were purified as described above with the addition of 10 mM 2-mercaptoethanol to all purification buffers.
Crystals of both native and selenomethionine-substituted oxidized Spx-␣CTD were grown by the hanging-drop vapor diffusion method. Two microliters of 0.5 mM Spx-␣CTD was mixed with 2 l of reservoir solution containing 1.6-2.0 M Li 2 SO 4 , 0.1 M sodium citrate (pH 5.6), and 0.1 M ammonium sulfate. Crystals appeared within 2-3 days and reached maximum dimensions of 0.2 ϫ 0.05 ϫ 0.05 mm 3 in Ϸ1 week. The crystallization solution was suitable as a cryoprotectant and crystals were flash-frozen in a nitrogen stream at Ϫ180°C. X-ray intensity data for native crystals were collected on beamline 8.2.1 at the Advanced Light Source (Lawrence Berkeley National Laboratory, Berkeley, CA), and data were processed by using MOSF LM (18) as implemented in the CCP4 suite of programs (19) ( Table 1 ). For crystals of the selenomethionine-substituted protein, x-ray intensity data were collected at beamline 4.2.2 at the Advanced Light Source, and data were processed and scaled by using d*TREK (20) ( Table 1) . Native crystals took space group R3 with cell dimensions a ϭ b ϭ 96.4 Å, c ϭ 57.1 Å, ␣ ϭ ␤ ϭ 90°, and ␥ ϭ 120°. The selenomethionine-substituted crystals also took space group R3 with cell dimensions a ϭ b ϭ 97.9 Å, c ϭ 57.4 Å, ␣ ϭ ␤ ϭ 90°, and ␥ ϭ 120°.
Structure Determination, Model Building, and Refinement. The structure of the selenomethionine-substituted Spx-␣CTD complex was solved by multiple-wavelength anomalous diffraction methods (MAD), using data collected at three wavelengths (Table 1) . Using data from 15.0-2.5 Å resolution, all six selenium sites were located and initial phases were calculated with SOLVE (21, 22) . Phases were improved by density modification, and a partial structure was built automatically by using RESOLVE (22, 23). Manual fitting of the remaining residues resulted in the placement of amino acid residues 1-118 of Spx and residues 245-311 of ␣CTD into the electron density map by using O (24) , with the positions of the selenomethionine residues as reference points. The initial protein model was subjected to rigid body refinement, followed by simulated annealing and positional and B-factor refinement in CNS (25) . After the addition of several water molecules, the R work and R free were 25.4% and 29.6%, respectively, and the model was further refined against native intensity data to 1.50 Å resolution. Further rounds of model building and solvent addition followed by positional and B-factor refinement resulted in a final model that contained residues 1-118 of Spx and residues 245-311 of ␣CTD, 143 water molecules, and 4 sulfate molecules. The final R work was 19.7%, and the final R free was 22.1%. The stereochemistry of the final model was assessed with PROCHECK (26) , which revealed 95.2% of all ͞ angles in the most favored regions of the Ramachandran plot and none in the generously allowed or disallowed regions.
Results and Discussion
Structure of Spx and ␣CTD. The global structure of Spx consists of a mixed ␣͞␤ topology with a central four-stranded ␤-sheet, which is flanked by two 3 10 -helices and four ␣-helices. The last 13 residues (119-131) are missing from the structure because of structural disorder. The C-terminal tail is necessary for recog- nition by the ClpXP protease, and its unstructured nature is not surprising (11) . The topology of the Spx structure is ␤1-␣1-␤2-␣2-␣3(3 10 )-␣4-␣5-␤3-␤4-␣6(3 10 ) (Fig. 1) . As predicted, the overall fold of Spx is structurally homologous to that of the E. coli ArsC with a root mean square deviation (rmsd) of 2.37 Å over residues 2-114 (Fig. 1 A) . ArsC is 9 residues longer with the last 20 residues forming an additional two-stranded ␤-sheet.
The CTD of the B. subtilis (Bsu) RNA polymerase ␣ subunit is composed of residues 246-311 and forms an independently folded domain of five loosely packed ␣-helices ( Fig. 1 B and C) . The equivalent residues of E. coli ␣CTD are numbered from 250 to 315, and for clarity the E. coli numbering will be provided in parentheses throughout the text (Fig. 1C Right) . This is the highest resolution structure of an ␣CTD determined to date, as well as the first structure of an ␣CTD from a Gram-positive bacterium. As expected, the Bsu ␣CTD is structurally homologous to the previously determined x-ray (27) and NMR structures (28, 29) of other ␣CTDs with an rmsd over all C␣ atoms of 0.90-1.98 Å (Fig. 1B) . It is of interest to note here that solvent-accessible residue Y263 (267) of the Bsu ␣CTD, which is necessary for the direct interaction of Spx and ␣CTD, is strictly conserved in all low GϩC Gram-positive species but not in Gram-negative organisms where the corresponding residue is often an alanine (14) .
As shown in previous genetic and biochemical studies (12), the conserved cysteines at positions 10 and 13 of oxidized Spx form a disulfide bond, which is located within the first turn of ␣1 (Fig.  2 A and B) . Interestingly, three Spx residues, R92, P93, and I94 (the RPI motif, Fig. 1 A) , are conserved in all Spx homologues and in ArsC (14) . The RPI motifs of Spx and ArsC are located at the N terminus of ␤3 and are proximal to the reactive cysteines of each protein (Figs. 1 A and 2 A) . In both the Spx and ArsC structures, residue P93 takes the less favorable cis configuration. The guanidinium side chain of Spx residue R92 is 3.6 Å from the sulfur atom of residue C10 and 5.0 Å from the sulfur atom of C13. The corresponding arginine in ArsC is hypothesized to lower the pK a of the active site cysteine, which is equivalent to Spx residue C10, that ligates the arsenate ion (15) . A similar role for R92 of Spx is envisioned in that by lowering the pK a of residue C10 or C13 under normal aerobic conditions the nucleophilic thiolate would form more readily at physiological pH and hence be an effective oxidative stress sensor. Intriguingly, in both the ArsC and Spx crystal structures, there is a sulfate molecule originating from the crystallization solution that interacts with this arginine (Fig. 2 A) . The possibility that this sulfate-binding site has biological relevance has been bolstered by recent findings of Zuber and coworkers (30) that reveal that when cells are grown with sulfate as the sole sulfur source, Spx regulates transcription of sulfur assimilation genes. Perhaps this conserved RPI motif is involved in both modulating the reactivity of C10 or C13 and binding sulfate in vivo.
Spx-␣CTD Complex. In B. subtilis the regulation of transcription by Spx under conditions of disulfide stress requires a direct interaction between Spx and ␣CTD (11) . Surprisingly, ␣CTD interacts with Spx on a face that is distal from the disulfide bridge (the closest distance is 26 Å), whereby ␣1 of ␣CTD and its preceding loop pack against the N terminus of ␣2 and ␣5 and a loop region between ␣2 and ␣3 of Spx (Fig. 1C) . The interface between the two proteins is relatively small and polar and buries 1,311 Å 2 of surface area per heterodimer out of a total accessible surface area of 10,564 Å 2 . Residues N264 (268), K267 (271), and R268 (272) from ␣1 of ␣CTD hydrogen bond with residues T53(NH and ␥-OH), R47(CO), and D54(COO Ϫ ) of Spx, respectively, which are located on ␣2 and ␣3 (Fig. 3A) . Interestingly, these Bsu ␣CTD residues overlap with a region of the E. coli ␣CTD identified as the interaction surface of several positively regulated transcription factors (31) (32) (33) (34) . Residues Q77 and Y80, which are located within the N terminus of ␣5 of Spx, are engaged in hydrogen bonds to ␣CTD residues E254(E258) (CO) and L256(L260) (CO), which are located in the loop region Nterminal to ␣1 (Fig. 3B) . In addition, the polypeptide backbone carbonyl oxygen and amide nitrogen of residues R261(R265) (NH) and L258(L262) (CO) of ␣CTD make hydrogen bonds to the polypeptide backbone amide nitrogen and carbonyl oxygens of residues E72(CO) and L76(NH) of Spx, respectively.
In previous work, Zuber and coworkers (1, 2, 6) showed that substitution of ␣CTD residues V260(V264) with alanine or Y263(A267) with cysteine or residue G52 of Spx with arginine resulted in loss of transcription activation or repression by Spx and that this loss of function was due to disruption of the direct interaction between Spx and ␣CTD. The structure of the Spx-␣CTD complex provides the atomic basis for these observations. Residues V260 and Y263 are found within the N-terminal portion of ␣1, which forms part of the interface with Spx (Fig.  3C) . The side chain of V260(V264) resides within a strictly hydrophobic environment and makes multiple van der Waals contacts with Spx residues T53, E72, M74, and L79. The phenolic moiety of Y263(A267) sits just above V260(V264) in the pocket and is in van der Waals contact with residues L46 and G52 of Spx. The side chains of Y263(A267) and N264(N268) lie within 3.8 Å and 3.6 Å of G52, respectively, thereby restricting the identity of position 52 to glycine to maintain the tightly packed dimer interface because substitution of G52 by an arginine would interfere sterically with the formation of the complex.
Possible Mechanisms for Transcription Regulation by Spx. Spx has been termed an ''anti-alpha'' factor because this protein is involved in disrupting activator-stimulated transcription at some promoters (14) . Activator-stimulated transcription at both class I and class II promoters involves a direct interaction between the activator protein and ␣CTD, which acts to recruit RNA polymerase to the promoter (35, 36) . Several determinants on ␣CTD have been implicated in both activator and UP element- dependent transcription activation in E. coli (7, 9) . In addition, the crystal structure of the ␣CTD-CAP-DNA complex has elucidated further the molecular details of the interaction of ␣CTD with DNA at class I and UP element promoter sites (27) . ␣-DNA interactions in B. subtilis, as in E. coli, have been shown to enhance transcription both in the presence and absence of activators (37, 38) . ␣CTD interacts with the DNA minor groove at A͞T-rich sequences, and several residues from ␣1, ␣3, and the turn following ␣3 make DNA backbone contacts. Bsu residues R261 and N264, the equivalent E. coli residues of which (R265 and N268) make direct contacts to DNA in the ␣CTD-DNA and ␣CTD-CAP-DNA structures, are involved in interactions with Spx in the Spx-␣CTD complex (Fig. 3 A and B) . However, residues R268, G292, K294, and S295, the equivalent E. coli residues of which (R272, G296, K298, and S299) are all involved in binding DNA in the ␣CTD-CAP-DNA structure, are still available to interact with DNA in the ␣CTD-Spx complex. Moreover, residue N264, although engaged in hydrogen bonds to Spx, could still make a hydrogen bond with the DNA backbone. Thus, Spx binding to ␣CTD does not preclude DNA binding by this RNA polymerase subunit. Indeed, electrophoretic mobility shift assays with an idealized UP-element promoter sequence show that Spx does not disrupt the ␣CTD-DNA interaction but rather appears to increase the affinity of ␣CTD for this DNA sequence (see Fig. 5 , which is published as supporting information on the PNAS web site). As described, Spx also interacts with the ''261'' determinant of ␣CTD, which encompasses residues E254 (258), E255 (259), and D257 (261). In E. coli the 261 determinant is important for interaction between ␣CTD and region 4 of 70 (9) (Fig. 4) . Recent mutational studies have shown that disruption of ␣CTD-4 interactions abrogates both UP element-and class I activator-stimulated transcription (39, 40) . Thus, Spx might repress activator-stimulated transcription at some promoters by using one or more mechanisms including disruption of ␣CTD interactions with an activator, region 4 of the RNA polymerase A subunit, or both. The mechanism(s) by which Spx acts to repress activatorstimulated transcription is readily envisioned, but the present crystal structure does not present a clear understanding of how the interaction between oxidized Spx, i.e., the disulfide bond form, and ␣CTD could act to enhance transcription from other promoters (12) . Zuber and colleagues (14) have shown both biochemically and genetically that under oxidizing conditions, a direct interaction of Spx with ␣CTD is necessary for activation of several genes, including trxA and trxB, and repression of transcription of others. Footprinting experiments of the trxA and trxB promoters revealed that RNA polymerase alone was able to protect a potential UP element positioned near nucleotide Ϫ60 of these promoters but was not sufficient for activation of transcription. Upon addition of Spx the footprint extended downstream to the Ϫ30 and Ϫ10 promoter regions (12) . These data suggest that in some promoter-specific instances, Spx acts in concert with the RNA polymerase holoenzyme to mediate formation of an active promoter complex. Perhaps Spx forms an additional interaction with other subunits particularly the sigma subunit or the ␣NTD to position RNA polymerase optimally for transcription from these promoters. Indeed, Zuber and coworkers (personal communication) have recently shown that mutations in region 4.2 of A affect transcription regulation by Spx. The structure of the oxidized Spx-␣CTD complex provides the first view of an ''anti-alpha'' factor and insight into several aspects of the multiple transcription regulation functions of this protein. A key question that remains is how does oxidation of residues C10 and C13 and their subsequent formation of a disulfide bond act to modulate the activity of Spx as a transcriptional regulator, especially given the distal location of the disulfide bond from the ␣CTD-Spx heterodimerization interface (Fig. 4) . One possibility is that formation of the disulfide bridge causes a conformational change that diverts Spx from the ClpXP proteolytic machinery, hence invoking a default functional state. This scenario is unlikely because Western blot analysis of cells expressing a C10A͞C13A double mutant of Spx, which is incapable of sensing disulfide stress, has shown no differences in protein levels as compared with those of wild-type cells (P.Z., unpublished results). Alternatively, a conformational change, which is associated with reduction, might be transmitted through the Spx structure to disrupt or alter the Spx-␣CTD interaction. However, initial isothermal titration calorimetry experiments suggest no differences in the affinity of Spx for ␣CTD in the presence or absence of reducing agent (K.J.N., unpublished results). Perhaps an interaction between Spx and the 4 A region is needed for its transcriptional regulation under oxidizing conditions; or alternatively, reduced Spx may be recognized and sequestered by another cellular factor such as MecA, which has been shown to interact with Spx (41). Additional biochemical, genetic, and structural studies are needed to explore this and other possibilities to understand fully the mechanisms of transcription regulation by Spx.
